Schedule 13G ownership disclosure
4D PHARMA PLC
Security class unavailable · CUSIP: 35085K109
Event date: 2021-03-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,000,000
- Percent of class
- 5.5900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-049070
- Form type
- SC 13G
- Filer
- 4D Pharma PLC
- CIK
- CIK 1830162
- Filed
- Apr 12, 2021
- Reporting period
- Mar 22, 2021
- Description
- Schedule 13G beneficial ownership